Insights into Company

Grasim Industries ↗

1948 📍 Ujjain, Madhya Pradesh, India Active NSE GRASIM CIN L17124MP1947PLC000410 Apparel, Textiles & Footwear
Search companies

Key Metrics of Grasim Industries

Revenue₹41,039 Cr▲ 30.0% YoYFY 2025-26
EBITDA₹3,429 Cr▲ 27.3% YoY
Net profit₹348 Cr▲ 64.3% YoY
Net worth₹55,277 Cr▲ 1.6% YoY
Competitors10identified

About Grasim Industries

Sectors

Apparel, Textiles & FootwearTextiles, Cotton & Yarn

Company details

Website
grasim.com
Founded
1948
Registered office
Birlagram, Nagda, Ujjain, In-mp, 456331
Listed
NSE: GRASIM · ₹2,900.00

Operational Areas of Grasim Industries

Apparel, Textiles & Footwear›Textiles, Cotton & Yarn

Company summary

Entity details

CINL17124MP1947PLC000410
LEI code335800WLY7FOIT3ERV21
State codeMP
PIN code456331
Current legal nameGRASIM INDUSTRIES
Classification—
Listing statusListed (NSE: GRASIM)
Registration no.000410
Company age78 years, 9 months
PAN—
CountryIndia
CityUjjain
StateMadhya Pradesh
Current statusActive
Date of incorporation01 Jan 1948
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code17124
Description of main activityManufacture of textiles
Description of business activityManufacture of textiles
SectorApparel, Textiles & Footwear · Textiles, Cotton & Yarn
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 2 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 32 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 22 Jul 2026 — Other
Change in last 12 monthsNo change
Change since first rating on recordNo changesince Jan 2018
Rating actions150 up · 0 down

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
22 Jul 2026CAREOther ———— View
06 Jul 2026CAREReaffirmed AAAA1+Stable₹17,275 Cr View
09 Jul 2025CAREReaffirmed AAAA1+Stable₹18,775 Cr View
09 Oct 2024CAREReaffirmed AAAA1+Stable₹17,275 Cr View
05 Jul 2024CAREReaffirmed AAAA1+Stable₹12,356 Cr View
05 Apr 2024CAREReaffirmed AAAA1+Stable₹12,356 Cr View
29 Jun 2023CAREReaffirmed AAAA1+Stable₹12,356 Cr View
05 Dec 2022CAREReaffirmed AAAA1+Stable₹14,712 Cr View
06 Dec 2021CAREReaffirmed AAAA1+Stable₹1,000 Cr View
05 Apr 2021CAREReaffirmed AAAA1+Stable₹7,356 Cr View
05 Feb 2021CAREOther —A1+—₹1,500 Cr View
09 Jul 2020CAREReaffirmed AAAA1+Stable₹4,856 Cr View
07 Feb 2020CAREReaffirmed AAAA1+Stable₹7,712 Cr View
19 Dec 2018CAREOther ———— View
18 Jan 2018CAREOther ———— View

Credit strengths (CARE, Jul 2026)

+ Leadership position in VSF industry and chemical sector

The Aditya Birla group is a global leader in VSF manufacturing and GIL is India’s pioneer in VSF, a man-made bio-degradable fibre with characteristics akin to cotton. VSF is widely used in apparel, home textiles, dress materials, knitted wear, and non-woven applications. VSF operations are largely integrated with pulp plants and caustic soda plants in India, captive thermal power plants and a strong product mix, leading to operational efficiency. In FY26, cellulosic fibres revenue improved to ₹1

+ Diversified business profile

GIL’s core businesses (on a standalone basis) comprise CSF, cellulosic fashion yarn (CFY), caustic soda, speciality chemicals, rayon-grade wool pulp (RGWP), decorative paints, B2B e-commerce, and other businesses, such as textiles and insulators. GIL has aggregate CSF capacity of 842 kilotonnes per annum (KTPA), CFY capacity of ~50 KTPA, caustic soda capacity of 1,505 KTPA, chlorine derivatives capacity of 996 KTPA, epoxy capacity of 246 KTPA, and decorative paints capacity of 1,332 million litr

+ Strong financial flexibility supported by strategic investments

GIL is the flagship company of the Aditya Birla group, benefits from strong financial flexibility, supported by its diversified presence across multiple business segments and substantial strategic investments. The Aditya Birla group, led by Kumar Mangalam Birla, has a significant presence across metals, cement, telecom, financial services, textiles, paints and other sectors, with GIL acting as a key holding entity within the group.

+ Improvement in operating performance in FY26

The company has strong fundamentals, characterised by a robust business model in its core business segments, high bargaining power with suppliers and customers, strong distribution network, and improving operating performance. In FY26, total operating income (TOI) increased 30% y-o-y to ₹41,039 crore and standalone EBITDA increased to ₹1,771 crore against ₹1,167 crore in FY25. Improvement in cellulosic fibres, chemicals and textiles supported performance, while the investment phase in Birla Opus

+ Chemical segment

In FY26, revenue from the chemicals segment improved by ~11% to ₹9,593 crore from ₹8,648 crore in FY25, supported by stable domestic demand and better volume performance across caustic and chlorine derivatives. Segment EBITDA improved to ₹1,406 crore in FY26, from ₹1,208 crore in FY25, with EBITDA margin improving to 14.66%. Caustic sales volumes stood at record levels in Q3FY26 and Q4FY26, at 313 KT and 321 KT, respectively; however, international caustic soda prices remained volatile.

+ Healthy financial risk profile

Healthy accruals in the last several years, resulted in GIL’s strong financial profile, despite investments in subsidiaries and related parties, and ongoing capex. Despite an increase in TD due to capital expenditure requirements, the company's debt coverage metrics remained comfortable in FY26. This was supported by healthy cash accruals and an increase in net worth.

Credit challenges

− Exposure to risks related to cyclicality in the VSF business

VSF demand remains impacted by downturns in the economy and faces intense competition from other fibres, mainly cotton and polyester staple fibre, leading to fluctuations in profitability. Although the China CSF market showed recovery in Q4FY26, the segment remains exposed to global demand-supply movement, input cost volatility and import competition in CFY. GIL’s strong market position, backward integration and focus on specialty fibre should support resilience through challenging business cycl

− Financial support to subsidiaries, associates, and group companies

GIL has been investing in subsidiaries, associates and group entities over the years through internal accruals, debt and liquidation of current investments. While some investments lend financial flexibility, capital calls towards subsidiaries/group companies or additional support may impact liquidity and remain a key rating monitorable. In FY26, GIL also approved subscription to equity shares of ABCL to the tune of ₹2,880 crore.

Could lead to a downgrade

• Higher-than-envisaged debt levels due to funding of ongoing capex and/or higher working capital requirements, leading to deterioration in its capital structure marked by overall gearing exceeding 0.50x. • Significant financial support to subsidiaries, associate companies, or group companies.

Agency-reported financials (CARE, 09 Oct 2024)

MetricQ1FY25
Total operating income₹6,987 Cr
PBILDT₹418 Cr
PAT₹-52.12 Cr
Overall gearing (times)—
Interest coverage (times)2.99×
EBITDA margin6.0%
Implied interest cost (EBITDA ÷ coverage)₹140 Cr
PAT margin−0.7%

Borrowings & rated debt

Rated borrowing limits (latest)₹17,275 Cr
Peak rated limits₹18,775 CrJul 2025 · CARE
Limits raised0 times0 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term bank facilitiesWorking capital & bank lines—₹9,525 Cr— AAA (Stable)ReaffirmedCARE
Short-term bank facilitiesWorking capital & bank lines—₹6,750 Cr— A1+ReaffirmedCARE
Non-convertible debenturesDebentures & bonds—₹1,000 Cr— AAA (Stable)ReaffirmedCARE

CARE ratings on record (checked 26 Oct 2026)

InstrumentAmountRating
BG/LC₹6,750 CrCARE A1+
CP/ Short Term loan—Withdrawn
Long Term₹3,675 CrCARE AAA; Stable
Non Convertible Debentures₹1,000 CrCARE AAA; Stable
Term Loan₹5,850 CrCARE AAA; Stable

Lenders

Fund-basedLong TermAxis Bank Ltd.
Fund-basedLong TermFederal Bank
Fund-basedLong TermHDFC Bank Ltd.
Fund-basedLong TermICICI Bank Ltd.
Fund-basedLong TermIDBI Bank Ltd.
Fund-basedLong TermIndusInd Bank Ltd.
Fund-basedLong TermKotak Mahindra Bank Ltd.
Fund-basedLong TermProposed
Fund-basedLong TermSouth Indian Bank Ltd.
Fund-basedLong TermState Bank of India
Fund-basedLong TermSumitomo Mitsui Banking Corporation
Fund-based - LTTerm LoanAxis Bank Ltd.
Fund-based - LTTerm LoanHDFC Bank Ltd.
Non-fund-based - STBG/LCAxis Bank Ltd.
Non-fund-based - STBG/LCHDFC Bank Ltd.
Non-fund-based - STBG/LCICICI Bank Ltd.
Non-fund-based - STBG/LCState Bank of India

Credit assessment · Cotton textile

Rating Methodology – Cotton Textile (Sep 2026) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStretched
DirectionStable

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Information on file56% · missing: Capex / investment plans, Lender details, Auditor details, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 41% (At risk of downgrade) · ML model on 4072 rating histories, AUC 0.666
Rated limits—
Not yet allocated—
Extra debt within 2.5× EBITDA—
Interest coverage—
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 41% chance the next rating action is stable or better

What happened, step by step

Refinanced bank debt with new funding from CCI
  1. Dec 2021 — Rated term loans fell from ₹6,356 cr to ₹0 cr
  2. Dec 2022 — ₹3,786 cr raised from CCI

“Status of income tax demand pertaining to the demerger of financial services and penalty levied by CCI: CARE Ratings notes the Competition Commission of India’s (CCI’s) order dated March 16, 2020, imposing a penalty of ₹301.61 crore in respect of the VSF turnover of the company as well as the demand of ₹3,786 crore (wh...”

Refinanced bank debt with new funding from DCIL
  1. Dec 2021 — Rated term loans fell from ₹6,356 cr to ₹0 cr
  2. Dec 2022 — ₹8,334 cr raised from DCIL

“An additional demand of ₹8,334 crore was raised in October 2021 by the DCIL on capital gains tax on the value of shares as per the above-mentioned scheme of arrangement.”

Refinanced bank debt with new funding
  1. Dec 2021 — ₹5,000 cr raised
  2. Dec 2021 — Rated term loans fell from ₹6,356 cr to ₹0 cr

“Rs.5,000 crore will be raised through a mix of debt and internal accruals.”

Refinanced bank debt with new funding from CCI CARE
  1. Apr 2021 — ₹66,351.51 cr raised from CCI CARE
  2. Dec 2021 — Rated term loans fell from ₹6,356 cr to ₹0 cr

“Status of income tax demand pertaining to demerger of financial services and Penalty levied by CCI CARE notes the Competition Commission of India’s (CCI’s) order dated March 16, 2020, imposing a penalty of Rs. 301.6 crore in respect of the VSF turnover of the company as well as the demand of Rs. 3,786.40 crore (which a...”

Rated limits by facility

Timeline

22 Jul 2026 CARE other: — CARE rationale
06 Jul 2026 CARE reaffirmed: AAA (Stable)Rated limits ₹17,275 cr CARE rationale
06 Jul 2026 ₹2,880 cr raised through equity from UCL
From the report

In FY27, GIL’s planned equity infusion of ₹2,880 crore into Aditya Birla Capital Limited (ABCL) and expected dividend inflows of ~₹4,000 crore from UCL, is likely to support overall stability in the company’s net debt position.

CARE rationale
06 Jul 2026 Cash & liquid funds ₹4,389 cr
From the report

The company had cash and cash equivalents (including liquid investments) of ~₹4,389 crore (as on March 31, 2026), which is sufficient to service scheduled term debt repayments of ₹93 crore in FY27.Market value of its investments in subsidiaries and group companies stood significantly high at ~₹2,50,845 crore as on June 17, 2026, providing significant financial flexibility. 3 CARE Ratings Ltd.

CARE rationale
09 Jul 2025 CARE reaffirmed: AAA (Stable)Rated limits ₹18,775 cr CARE rationale
09 Jul 2025 ₹3,974 cr raised through equity
From the report

In FY24 and FY25, the company has received rights issue proceeds (net of rights issue expenses) of ₹3,974 crore.

CARE rationale
09 Jul 2025 Cash & liquid funds ₹4,229 cr
From the report

The company had cash and cash equivalents (including liquid investments) of ₹4,229 crore (as on March 31, 2025), which is over sufficient to service scheduled term debt repayments of ₹32 crore in FY26.

CARE rationale
09 Oct 2024 CARE reaffirmed: AAA (Stable)Rated limits ₹17,275 cr CARE rationale
09 Oct 2024 Cash & liquid funds ₹3,472 cr
From the report

The company had cash and cash equivalents (including liquid investments) of about ₹3,472 crore (as on March 31, 2024), which is sufficient to service scheduled term debt repayments of ₹1,270 crore in FY25.

CARE rationale
05 Jul 2024 CARE reaffirmed: AAA (Stable)Rated limits ₹12,356 cr CARE rationale
05 Jul 2024 Cash & liquid funds ₹3,472 cr
From the report

The company had cash and cash equivalents (including liquid investments) of about ₹3,472 crore (as on March 31, 2024), which is sufficient to service scheduled term debt repayments of ₹1,270 crore in FY25.

CARE rationale
05 Apr 2024 CARE reaffirmed: AAA (Stable)Rated limits ₹12,356 cr CARE rationale
05 Apr 2024 Cash & liquid funds ₹3,216 cr
From the report

The company has cash and cash equivalents (including liquid investments) of about ₹3,216 crore (as on September 30, 2023), which is sufficient to service the scheduled debt repayments of ₹768 crore in FY24.

CARE rationale
29 Jun 2023 CARE reaffirmed: AAA (Stable)Rated limits ₹12,356 cr CARE rationale
29 Jun 2023 ₹3,786 cr raised from CCI
From the report

Status of income tax demand pertaining to the demerger of financial services and penalty levied by CCI: CARE Ratings notes the Competition Commission of India’s (CCI’s) order dated March 16, 2020, imposing a penalty of ₹301.61 crore in respect of the VSF turnover of the company as well as the demand of ₹3,786 crore (which was reduced from ₹5,872 crore in October 2020) raised by the Deputy Commissioner of Income Tax (DCIT) on account of dividend distribution tax (DDT, including interest), pursuant to the composite Scheme of Arrangement between Grasim, ABNL,and Aditya Birla Financial Services Li

CARE rationale
29 Jun 2023 ₹8,334 cr raised from DCIT
From the report

An additional demand of ₹8,334 crore was raised in October 2021 by the DCIT on capital gains tax on the value of shares as per the above-mentioned scheme of arrangement.

CARE rationale
29 Jun 2023 Average working-capital utilisation 3%
From the report

The low average utilisation of 3% for the trailing 12 months ended May 31, 2023, for fund-based limits under consortium and cash and cash equivalents (including liquid investments) of about ₹2,932 crore (as on March 31, 2023) is sufficient to service the scheduled debt repayments of ₹768 crore in FY24.

CARE rationale
29 Jun 2023 Cash & liquid funds ₹2,932 cr
From the report

The low average utilisation of 3% for the trailing 12 months ended May 31, 2023, for fund-based limits under consortium and cash and cash equivalents (including liquid investments) of about ₹2,932 crore (as on March 31, 2023) is sufficient to service the scheduled debt repayments of ₹768 crore in FY24.

CARE rationale
05 Dec 2022 CARE reaffirmed: AAA (Stable)Rated limits ₹14,712 cr CARE rationale
05 Dec 2022 ₹3,786 cr raised from CCI
From the report

Status of income tax demand pertaining to the demerger of financial services and penalty levied by CCI: CARE Ratings notes the Competition Commission of India’s (CCI’s) order dated March 16, 2020, imposing a penalty of ₹301.61 crore in respect of the VSF turnover of the company as well as the demand of ₹3,786 crore (which was reduced from ₹5,872 crore in October 2020) raised by the Deputy Commissioner of Income Tax (DCIT) on account of dividend distribution tax (DDT, including interest), pursuant to the composite Scheme of Arrangement between Grasim, ABNL , and Aditya Birla Financial Services

CARE rationale
05 Dec 2022 ₹8,334 cr raised from DCIL
From the report

An additional demand of ₹8,334 crore was raised in October 2021 by the DCIL on capital gains tax on the value of shares as per the above-mentioned scheme of arrangement.

CARE rationale
05 Dec 2022 Average working-capital utilisation 2%
From the report

The low average utilisation of 2% for the trailing 12 months ended October 31, 2022, for fund-based limits under consortium and cash and cash equivalents (including liquid investments) of about ₹5,145 crore (as on September 30, 2022) is sufficient to service the scheduled debt repayments of ₹1,067.06 crore in FY23.

CARE rationale
05 Dec 2022 Cash & liquid funds ₹5,145 cr
From the report

The low average utilisation of 2% for the trailing 12 months ended October 31, 2022, for fund-based limits under consortium and cash and cash equivalents (including liquid investments) of about ₹5,145 crore (as on September 30, 2022) is sufficient to service the scheduled debt repayments of ₹1,067.06 crore in FY23.

CARE rationale
06 Dec 2021 CARE reaffirmed: AAA (Stable)Rated limits ₹1,000 cr CARE rationale
06 Dec 2021 ₹5,000 cr raised
From the report

Rs.5,000 crore will be raised through a mix of debt and internal accruals.

CARE rationale
06 Dec 2021 ₹8,334 cr raised from DCIL
From the report

An additional demand of Rs.8,334 crore was raised in October 2021 by the DCIL on capital gains tax on the value of shares as per the above-mentioned scheme of arrangement.

CARE rationale
06 Dec 2021 Average working-capital utilisation 6%
From the report

Low average utilisation of 6% for the trailing 12 months October 2021 for fund-based limits under consortium and cash & cash equivalents (incl. liquid investments) over Rs.3,036 crore (as on September 30, 2021) is sufficient to service scheduled debt repayments of Rs. 110.96 crore in FY22.

CARE rationale
06 Dec 2021 Cash & liquid funds ₹3,036 cr
From the report

Low average utilisation of 6% for the trailing 12 months October 2021 for fund-based limits under consortium and cash & cash equivalents (incl. liquid investments) over Rs.3,036 crore (as on September 30, 2021) is sufficient to service scheduled debt repayments of Rs. 110.96 crore in FY22.

CARE rationale
06 Dec 2021 Rated term loans fell from ₹6,356 cr to ₹0 cr CARE rationale
06 Dec 2021 ₹4,856 cr of limits rated but not yet allocated to a lender CARE rationale
05 Apr 2021 CARE reaffirmed: AAA (Stable)Rated limits ₹7,356 cr CARE rationale
05 Apr 2021 Cash & liquid funds ₹2,649 cr
From the report

The board of directors on November 12, 2020 approved the sale of company's fertilizer business –Indo Gulf Fertilizers on a going concern basis to Indorama India Private Limited through slumpsale for a lump sum cash consideration of Rs. 2,649 crore, subject to working capital adjustments and requisite approvals.

CARE rationale
05 Apr 2021 ₹66,351.51 cr raised from CCI CARE
From the report

Status of income tax demand pertaining to demerger of financial services and Penalty levied by CCI CARE notes the Competition Commission of India’s (CCI’s) order dated March 16, 2020, imposing a penalty of Rs. 301.6 crore in respect of the VSF turnover of the company as well as the demand of Rs. 3,786.40 crore (which as per the company has reduced from Rs. 6,6351.51 crore as on March 31, 2020) raised by the Deputy Commissioner of Income Tax (DCIT) on account of dividend distribution tax (DDT, including interest), pursuant to the composite Scheme of Arrangement between Grasim, Aditya Birla Nuvo

CARE rationale
05 Apr 2021 Average working-capital utilisation 23.35%
From the report

Low average utilisation of 23.35% for trailing 12 months November 2020 for fund based limits under consortium and cash & cash equivalents (incl. liquid investments) over Rs. 2,600 crore (as on September 30, 2020) is sufficient to service scheduled debt repayments of Rs. 181 crore in FY21.

CARE rationale
05 Apr 2021 Cash & liquid funds ₹2,600 cr
From the report

Low average utilisation of 23.35% for trailing 12 months November 2020 for fund based limits under consortium and cash & cash equivalents (incl. liquid investments) over Rs. 2,600 crore (as on September 30, 2020) is sufficient to service scheduled debt repayments of Rs. 181 crore in FY21.

CARE rationale
05 Feb 2021 CARE other: A1+Rated limits ₹1,500 cr CARE rationale
05 Feb 2021 Cash & liquid funds ₹2,649 cr
From the report

The board of directors on November 12, 2020 approved the sale of company's fertilizer business – Indo Gulf Fertilizers on a going concern basis to Indorama India Private Limited through slump sale for a lump sum cash consideration of Rs. 2,649 crore, subject to working capital adjustments and requisite approvals.

CARE rationale
05 Feb 2021 ₹66,351.51 cr raised from CCI CARE
From the report

Status of income tax demand pertaining to demerger of financial services and Penalty levied by CCI CARE notes the Competition Commission of India’s (CCI’s) order dated March 16, 2020, imposing a penalty of Rs. 301.6 crore in respect of the VSF turnover of the company as well as the demand of Rs. 3,786.40 crore (which as per the company has reduced from Rs. 6,6351.51 crore as on March 31, 2020) raised by the Deputy Commissioner of Income Tax (DCIT) on account of dividend distribution tax (DDT, including interest), pursuant to the composite Scheme of Arrangement between Grasim, Aditya Birla Nuvo

CARE rationale
05 Feb 2021 Average working-capital utilisation 23.35%
From the report

Low average utilisation of 23.35% for trailing 12 months November 2020 for fund based limits under consortium and cash & cash equivalents (incl. liquid investments) over Rs. 2,600 crore (as on September 30, 2020) is sufficient to service scheduled debt repayments of Rs. 181 crore in FY21.

CARE rationale
05 Feb 2021 Cash & liquid funds ₹2,600 cr
From the report

Low average utilisation of 23.35% for trailing 12 months November 2020 for fund based limits under consortium and cash & cash equivalents (incl. liquid investments) over Rs. 2,600 crore (as on September 30, 2020) is sufficient to service scheduled debt repayments of Rs. 181 crore in FY21.

CARE rationale
05 Feb 2021 Rated term loans fell from ₹606 cr to ₹0 cr CARE rationale
05 Feb 2021 ₹1,500 cr of limits rated but not yet allocated to a lender CARE rationale
09 Jul 2020 CARE reaffirmed: AAA (Stable)Rated limits ₹4,856 cr CARE rationale
09 Jul 2020 ₹1,000 cr raised
From the report

Outlook: Stable) *Interchangeable between CP issue of Rs.1000 crore and Short Term Bank Loan (STL) of equivalent amount.

CARE rationale
09 Jul 2020 ₹5,872.3 cr raised from CCI
From the report

Status of income tax demand pertaining to demerger of financial services and Penalty levied by CCI An income tax demand of Rs. 5,872.3 crore ha s been raised by Deputy Commissioner of Income Tax (DCIT) on account of dividend distribution tax (DDT, including interest), pursuant to the composite Scheme of Arrangement between Grasim, Aditya Birla Nuvo Limited (ABNL) and Aditya Birla Financial Service s Limited (now known as ABCL).

CARE rationale
09 Jul 2020 Average working-capital utilisation 10%
From the report

Low average utilisation of les s than 10% for trailing 12 months May 2020 for fund based limits under consortium and cash & cash equivalents of more than Rs. 2,000 crore (as on May 31, 2020) is sufficient to service scheduled debt repayments of Rs. 124 crore in FY21.

CARE rationale
09 Jul 2020 Cash & liquid funds ₹2,000 cr
From the report

Low average utilisation of les s than 10% for trailing 12 months May 2020 for fund based limits under consortium and cash & cash equivalents of more than Rs. 2,000 crore (as on May 31, 2020) is sufficient to service scheduled debt repayments of Rs. 124 crore in FY21.

CARE rationale
07 Feb 2020 CARE reaffirmed: AAA (Stable)Rated limits ₹7,712 cr CARE rationale
07 Feb 2020 ₹1,000 cr raised
From the report

Outlook: Stable) *Interchangeable between CP issue of Rs.1000 crore and Short Term Bank Loan (STL) of equivalent amount.

CARE rationale
07 Feb 2020 ₹5,872.3 cr raised
From the report

Status of income tax demand pertaining to demerger of financial services An income tax demand of Rs. 5,872.3 crore has been raised by Deputy Commissioner of Income Tax (DCIT) on account of dividend distribution tax (DDT, including interest), pursuant to the composite Scheme of Arrangement between Grasim, Aditya Birla Nuvo Limited (ABNL) and Aditya Birla Financial Services Limited (now known as ABCL).

CARE rationale
07 Feb 2020 Average working-capital utilisation 3.75%
From the report

Low average utilisation of 3.75% for trailing 12 months Dec 2019 for fund based limits under consortium and envisaged GCA of Rs. 2,122 crore is sufficient to service scheduled debt repayments and interest of Rs. 776 crore in FY20.

CARE rationale
07 Feb 2020 New borrowing arranged: ₹2,000 cr (term loans)
From the report

As per the management, the company also has out of consortium fund based and non-fund based sanctioned limits of Rs. 2,000 crore each which can be utilised to support its working capital requirements.

CARE rationale
07 Feb 2020 ₹4,106 cr of limits rated but not yet allocated to a lender CARE rationale
19 Dec 2018 CARE other: — CARE rationale
19 Dec 2018 ₹1,000 cr raised through commercial paper
From the report

Outlook: Stable) CARE A1+ Commercial Paper (CP) Issue Proposed* 1500 Reaffirmed (A One Plus) *Interchangeable between CP issue of Rs.1000 crore and Short Term Bank Loan (STL) of equivalent amount.

CARE rationale
19 Dec 2018 Cash & liquid funds ₹2,695 cr
From the report

Overall gearing stood at 0.07x as on March 31, 2018, however it has liquid investments aggregating Rs.2,695 crore as on March 31, 2018 (against total debt of Rs.2,385 crore as on March 31, 2017) consequent into net cash surplus as on March 31, 2018.

CARE rationale
19 Dec 2018 Cash & liquid funds ₹8,189 cr
From the report

Also, on consolidated basis, Grasim had liquid investments balance of Rs.8,189 crore and GCA of Rs.6,627 crore for FY2017-18.

CARE rationale
19 Dec 2018 Average working-capital utilisation 5%
From the report

Besides, average fund based limit utilization was less than 5% for last 12 months ended October 2018 signifying adequate cushion.

CARE rationale
19 Dec 2018 Cash & liquid funds ₹2,436 cr
From the report

Additionally, Grasim’s gross cash accruals remained strong at Rs.2,436 crore in FY18 (vis-à-vis Rs.2,042 crore FY17) consequent into healthy operating cash-flows and operating free cash-flows.

CARE rationale
18 Jan 2018 CARE other: — CARE rationale
18 Jan 2018 ₹1,000 cr raised
From the report

One Thousand Five Hundred Crore only) *Interchangeable between CP issue of Rs.1000 crore and Short Term Bank Loan (STL) of equivalent amount.

CARE rationale
18 Jan 2018 Cash & liquid funds ₹2,042 cr
From the report

Its cash accruals aggregated Rs.2,042 crore in FY17 (vis-à-vis Rs.1,451 crore FY16).

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeBIRLAGRAM, NAGDA, UJJAIN, IN-MP, 456331
GSTIN—
Email—
Websitehttps://www.grasim.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Grasim Industries

Competitors10identified
Locations1most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Arvind Limited Textiles, Cotton & Yarn · Apparel, Textiles & Footwear arvind.com — Ahmedabad, India
Welspun Living Textiles, Cotton & Yarn · Apparel, Textiles & Footwear welspunliving.com — Anjar, India
Raymond Formal & Premium Menswear · Apparel, Textiles & Footwear raymond.in — Ratnagiri, India
Alok Industries Discovered Companies · Other Industries alokind.com 1986 Silvassa, India
KPR Mill Textiles, Cotton & Yarn · Apparel, Textiles & Footwear kprmilllimited.com — India
Page Industries Textiles, Cotton & Yarn · Apparel, Textiles & Footwear pageind.com 1995 Bengaluru, India
Indo Count Industries Textiles, Cotton & Yarn · Apparel, Textiles & Footwear indocount.com — Kolhapur, India
Nahar Spinning Mills Textiles, Cotton & Yarn · Apparel, Textiles & Footwear owmnahar.com — Ludhiana, India
Greaves Cotton Textiles, Cotton & Yarn · Apparel, Textiles & Footwear greavescotton.com 1859 Aurangabad, India
Siyaram Silk Mills Formal & Premium Menswear · Apparel, Textiles & Footwear siyaram.com 1978 Boisar, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

VSF fibre, chemicals and paints

Filings

No filings on record yet.